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Abstract
The opportunistic pathogen Pseudomonas aeruginosa is able to thrive in diverse ecological niches and to cause serious
human infection. P. aeruginosa environmental strains are producing various virulence factors that are required for
establishing acute infections in several host organisms; however, the P. aeruginosa phenotypic variants favour long-term
persistence in the cystic fibrosis (CF) airways. Whether P. aeruginosa strains, which have adapted to the CF-niche, have lost
their competitive fitness in the other environment remains to be investigated. In this paper, three P. aeruginosa clonal
lineages, including early strains isolated at the onset of infection, and late strains, isolated after several years of chronic lung
infection from patients with CF, were analysed in multi-host model systems of acute infection. P. aeruginosa early isolates
caused lethality in the three non-mammalian hosts, namely Caenorhabditis elegans, Galleria mellonella, and Drosophila
melanogaster, while late adapted clonal isolates were attenuated in acute virulence. When two different mouse genetic
background strains, namely C57Bl/6NCrl and Balb/cAnNCrl, were used as acute infection models, early P. aeruginosa CF
isolates were lethal, while late isolates exhibited reduced or abolished acute virulence. Severe histopathological lesions,
including high leukocytes recruitment and bacterial load, were detected in the lungs of mice infected with P. aeruginosa CF
early isolates, while late isolates were progressively cleared. In addition, systemic bacterial spread and invasion of epithelial
cells, which were detected for P. aeruginosa CF early strains, were not observed with late strains. Our findings indicate that
niche-specific selection in P. aeruginosa reduced its ability to cause acute infections across a broad range of hosts while
maintaining the capacity for chronic infection in the CF host.
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Introduction
Pseudomonas aeruginosa is a common bacterium found in a wide
range of environments; it infects nematodes, insects, plants, and
ameba in the laboratory and probably encounters a similar range
of potential hosts in the wild [1]. In humans, P. aeruginosa causes a
wide range of infections, including deadly pneumonia when
infecting immuno-compromised or cystic fibrosis (CF) patients.
The clinical outcome of P. aeruginosa infection ranges from acute to
chronic infections. Individuals in intensive care units can develop
ventilator-associated pneumonia and/or sepsis as a result of P.
aeruginosa infection. Patients with CF develop life-long chronic lung
P. aeruginosa infection which leads to death.
Genomes of different P. aeruginosa isolates share a remarkable
amount of sequence similarity when isolated from the environment
or from different clinical origins [2,3]. A considerable conservation
of genes including nearly all known virulence factors, such as
pyocyanin, a type III secretion system (T3SS), several proteases,
lipases and phospholipases and rhamnolipids was observed in P.
aeruginosa strains isolated from the environment, immuno-compro-
mised patients and CF patients at the onset of infection [3].
Despite the overall genome similarity among diverse P. aeruginosa
strains, point mutations accumulate in bacterial lineages persisting
in CF airways. Mutations commonly acquired by P. aeruginosa
strains during CF chronic infection are those in the regulators of
alginate biosynthesis [4] and virulence genes involved in the LPS
modification [5], motility [6], in the quorum-sensing regulation
[7,8], in biosynthesis of the T3SS [9] and multidrug-efflux pumps,
and in mutator genes [10]. Changes in metabolic functions have
also been described [11]. In addition, whole genome sequence
analysis of P. aeruginosa longitudinal strains from the same CF
patient revealed that a surprisingly large number of genes in the
genome can be targets for mutation during adaptation to CF
airways, although only a few of these genes were found to be
affected in many of the late isolates [11]. Recent work
demonstrated that the greatest contribution to the extremely high
levels of genetic diversity is within an individual patient rather than
between patients [12].
Pathogenicity of P. aeruginosa isolates from different habitats and
clinical origin, including complex phenotypes from CF patients,
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reference strains PA14 and PAO1, and additional strains from
various sources, showed that the genes required for pathogenicity
in one strain are neither required for nor predictive of virulence in
other strains [2]. When comparing P. aeruginosa strains derived
from the same type of infection, there was no consistent clustering
with respect to their phenotype in C. elegans [2]. For example,
urinary tract infection strains exhibited a wide range of virulent
and avirulent phenotypes in acute infection models. In the same
vein, both the most and the least virulent strains tested were
isolates from CF infections. Taken together, these results suggest
that virulence and in particular pathogenicity-related genes in
different organisms are both multifactorial and combinatorial, and
that the outcome of a specific host-pathogen interaction depends
on the bacterial origin as well as on the host genetic background.
Recent whole genome sequence analyses of P. aeruginosa strains
isolated from CF patients described loss-of-function mutations in
virulence genes, suggesting attenuation of virulence for CF-
adapted strains [13]. In the case of CF infections, P. aeruginosa
clonal populations remain isolated in a defined environment over a
long period of time and normally do not spread to other patients.
Whether P. aeruginosa phenotypes that have adapted to the CF-
niches, have lost their competitive fitness in other environment is
not known.
To expand our knowledge on P. aeruginosa virulence and how
this bacterium interacts with its host, we tested the hypothesis that
CF-niche adaptation and specialization reduces the bacterial
pathogenic potential of the organism in acute infection models.
We selected well characterized P. aeruginosa clonal lineages of
strains isolated from three CF patients at the onset of infections
and after several years of chronic colonization; the samples
included late adapted strains carrying several phenotypic changes
in virulence factor production, structural modification in the
Pathogen-Associated Molecular Patterns (PAMPs) [14,5], and
patho-adaptive mutations within the genome temporally associat-
ed with CF lung infection [15]. These P. aeruginosa clonal lineages
were tested in a multiple infection hosts, including Caenorhabditis
elegans, Galleria mellonella, Drosophila melanogaster and mice with two
different genetic backgrounds, C57bl/6NCrl and Balb/cAnNCrl,
described previously as susceptible and resistant [16]. We showed
that P. aeruginosa early strains were lethal in the multi-host models
included in this study while late strains reduced or abolished acute
virulence. Our findings suggest that the adaptation of different P.
aeruginosa lineages within CF lungs selects populations with reduced
pathogenic potential in acute infections which is maintained across
a broad range of hosts.
Results
Pathogenic potential of P. aeruginosa sequential strains
from CF patients in C. elegans, D. melanogaster and G.
mellonella
P. aeruginosa longitudinal strains isolated from three CF patients
at the onset of infection (early) and after several years of chronic
colonization (late) and carrying several phenotypic differences
(Figure 1 and Table S1) were tested for their virulence potential
in three non-mammalian hosts, namely C. elegans, D. melanogaster
and G. mellonella. In these experiments early P. aeruginosa strains,
AA2, KK1, KK2 and MF1, and late strains, AA43, AA44, KK71,
KK72 and MF51 were administered to non-mammalian hosts and
mortality was monitored. P. aeruginosa early strain AA2 was
significantly more lethal than the clonal late isolates AA43 and
AA44 in C. elegans (AA2: 100% vs AA43: 21% and AA44: 41%,
Mantel-Cox test: p,0.001) (Fig. 2A). Similar results were also
obtained in D. melanogaster (AA2: 100% vs AA43: 82% and AA44:
97% p,0.001)(Fig. 2D). Although the late strains AA43 and
AA44 were more pathogenic in this model in comparison to C.
elegans, they killed the fruit flies later in comparison to the early
strain AA2. Likewise, early P. aeruginosa isolates from patients KK
and MF were significantly more lethal than their clonal late
isolates in both models. However, lethality in C. elegans (KK1: 25%
and KK2: 36% vs KK71: 11% and KK72: 7%, p,0.01; MF1:
69% vs MF51: 35%, p,0.001) (Fig. 2B, C) was generally less
severe than in D. melanogaster (KK1: 100% and KK2: 100% vs
KK71: 16% and KK72: 35%, p,0.01; MF1: 99% vs MF51: 11%,
p,0.001) (Fig. 2E, F). We also evaluated lethality in a G. mellonella
infection model. As in the previous models, the LD50 of the early
isolate AA2 was found to be more than 20-folds reduced when
compared to the clonal late isolates AA43 and AA44 (Table 1).
Similar trends were also seen with the sets of early and late isolates
(KK and MF isolates). The LD50 of the early isolates KK1 and
KK2 were found to be more than 20-folds reduced when
compared to the clonal late isolates KK71 and KK72. The early
isolate MF1 showed a LD50 of 1500-folds reduced when compared
to the clonal late isolate MF51, confirming the higher acute
virulence of early strains.
Response of different C57Bl/6NCrl and Balb/cAnNCrl
inbred mouse strains to infection with P. aeruginosa
sequential strains
To test whether the differences in lethality between early and
late clonal P. aeruginosa strains are maintained in the mammalian
host, we analyzed the host response in murine models of acute
pneumonia. Lethality and changes in body weight in C57Bl/
6NCrl and Balb/cAnCrl inbred mouse strains were assessed. First,
Figure 1. Genotypic and phenotypic characteristic of P.
aeruginosa sequential isolates from CF patients. Three clonal
lineages (AA, KK and MF) of P. aeruginosa strains were isolated at the
onset of chronic colonization (early: AA2, KK1, KK2, MF1) or several years
after acquisition and before patient’s death (late: AA43, AA44, KK71,
KK72, MF51). Clonality of strains was assessed by Pulsed Field Gel
Electrophoresis and was reported previously [4]. Multiple phenotypic
traits changed during genetic adaptation to the CF lung and included
[14]: (a) motility defect, (b) mucoid phenotype, (c) protease reduction,
(d) siderophore reduction, (e) hemolysis reduction, (f) LasR phenotype,
(g) growth rate reduction. In addition, lipopolysaccharide (LPS) lipid A
(h) and peptidoglycan (PGN) muropeptides (i) were analysed exclusively
in the lineage AA showing specific structural modifications temporally
associated with CF lung infection as described previously [5]. Additional
data were reported in the online data supplement (Table S1).
doi:10.1371/journal.pone.0035648.g001
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5 to 10
9 cfu of P. aeruginosa were
applied to C57Bl/6NCrl mice to determine the relative range of
susceptibility. As shown in Fig. 3 and Table S2, C57Bl/6NCrl
died starting from 5610
6 cfu/lung of early AA2 strain and
1610
7 cfu/lung of early KK1 and KK2 strains, indicating
differences in virulence between P. aeruginosa early strains of
different lineages. When mice were inoculated at the same doses,
late AA43, AA44, KK71 and KK72 strains were not lethal,
indicating that their virulence was attenuated in comparison to the
early strains (AA2 vs AA43 and AA44, p,0.001; KK1 and KK2
vs KK71 and KK72, Mantel-Cox, p,0.001) (Fig. 4A and B). In
the AA lineage, all mice died at doses of 10
8 cfu/lung of AA43 and
AA44 strains (Fig. 3A), while in the KK lineage doses of 10
9 cfu/
lung of KK71 and 10
8 cfu/lung of KK72 were fully lethal
(Fig. 3B). Differences between early and late strains were also
observed in BALB/cAnNCrl mice (AA2 vs AA43 and AA44,
p,0.05; KK1 and KK2 vs KK71 and KK72, p,0.01) (Fig. 4C
and D), which showed similar susceptibility as C57Bl/6NCrl.
Bacterial cells were recovered from blood and other organs of
moribund mice indicating that death was caused by sepsis (data
not shown).
In accordance with these results, a major decrease in body
weight was observed in mice infected with the early P. aeruginosa
strains AA2, KK1 and KK2 when compared with the late clonal
strains AA43, AA44 and KK71 both in C57Bl/6NCrl and Balb/
cAnCrl (Fig. S1). Infections with KK72 strain appeared to be an
exception.
Histopathological lesions, localization and quantification
of P. aeruginosa strains in the murine airways
To assess clinical strain-specific traits of acute pneumonia, lung
histopathology was performed on mice challenged with strains of
the P. aeruginosa AA clonal lineage for 24 hours. This analysis
revealed that acute infection with early AA2 strain caused more
severe lesions and leukocytes recruitment in the airways than
infection with late AA43 and AA44 (Fig. 5 A–C, E–G). The area
infiltrated with inflammatory cells was significantly increased in
the AA2 strain compared to AA43 and AA44 infected mice (cell
infiltration mean6SEM: 63.9965.42% of AA2 vs 43.1560.91%
of AA43 and 44.5160.44% of AA44, Mann Whitney test,
p,0.05) (Fig. 5O). Accordingly, the percentage of tissue
preservation was significantly higher for AA43 and AA44
compared to AA2 (36.0165.42% of AA2 vs 56.8560.91% of
AA43 and 55.4960.44% of AA44, p,0.05).
Immunofluorescence staining showed that the early strain AA2
was localized both within the bronchial lumen and within alveolar
space (Fig. 5I), supporting its spreading to other organs during
sepsis. In contrast, the late strains AA43 and AA44 were localized
exclusively within the bronchia (Fig. 5L, M). Next, we quantified
the bacterial load in the lungs of mice up to 48 h post infection.
Given a starting dose of 5610
6, early AA2 strain replicated in the
airways reaching a high load (2.3610
8 median CFU) and causing
death of the animal (Fig. 5P). Late AA43 and AA44 decreased
significantly bacterial numbers soon after infection and were
completely cleared by the host immune system after 48 h,
indicating a low pathogenic potential (AA2 vs AA43 and AA44,
Student’s t-test, p,0.05).
Figure 2. Pathogenicity of clonal pair of early/late P. aeruginosa isolates in C. elegans and D. melanogaster. Pathogenicity of lineages of
early and late P. aeruginosa isolates in C. elegans: AA, (A); KK, (B); MF, (C); Pathogenicity of different lineages of early and late P. aeruginosa isolates in
D. melanogaster: AA lineage, (D); KK lineage, (E); MF lineage, (F). Three independent experiments were pooled. Statistical analysis was calculated for
pair wise comparisons between early and late strains (** p,0.01, *** p,0.001, Mantel-Cox test).
doi:10.1371/journal.pone.0035648.g002
Table 1. LD50 of longitudinal clonal P. aeruginosa lineages in
G. mellonella larvae 24 hours post infection.
Strain Nr. of Cells (LD50)
AA2 15
AA43 .3610
2
AA44 .3610
2
KK1 1.3610
3
KK2 2.8610
4
KK71 .6.0610
5
KK72 .7.0610
5
MF1 2.0610
2
MF51 .3.0610
5
.LD50 is higher than the maximum infection dosage used. Data represent
mean values of at least three independent experiments.
doi:10.1371/journal.pone.0035648.t001
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Bacterial invasion of host cells is a process common to many
pathogens, including the CF-related pathogen, to evade extracel-
lular immune factors [17] or to favour systemic spread [18]. We
tested the ability of the P. aeruginosa clinical strains to invade CF
respiratory cells (IB3-1) and isogenic corrected cells (C38). As
shown in Fig. 6, early AA2 strain was found to be significantly
more invasive than the P. aeruginosa clonal late strains AA43 and
AA44 in both IB3-1 and C38 cells (IB3-1: AA2 vs AA43 p,0.05,
AA2 vs AA44 p,0.001; C38: AA2 vs AA43 p,0.001, AA2 vs
AA44, Student’s t-test: p,0.001). In particular, AA44 strain was
completely non-invasive in these experiments. Similar results were
obtained with strains of the KK lineage. Early KK1 was
significantly more invasive when compared to late KK71 and
KK72 strains (IB3-1: KK1 vs KK71 and KK72, p,0.01 and
p,0.001, respectively; C38: KK1 vs KK71 and KK72, p,0.01
and p,0.001, respectively). Early KK2 strain was more invasive
than late clonal strains KK71 and KK72 both in IB3-1 and C38
cells, although significance was found only in IB3-1 cells (KK2 vs
KK71, p,0.01).
Figure 3. Correlation between survival percent and initial infection dose of clonal pair of early/late P. aeruginosa isolates in C57Bl/
6NCrl. C57Bl/6NCrl mice were infected with different doses of P. aeruginosa strains from AA (A) and KK (B) clonal lineages. Survival of infected mice
was followed over a period of 4 days and is indicated as a cumulative percent. Higher doses of late P. aeruginosa strains (AA43, AA44, KK71, KK72) are
required for mortality when compared to early strains (AA2, KK1 and KK2). Two to three independent experiments were pooled (nr of mice: 5–18 as
detailed in table S2). Statistical analysis of pair wise comparisons for early and late strains are indicated *** p,0.001 (Mantel-Cox test).
doi:10.1371/journal.pone.0035648.g003
Figure 4. C57Bl/6NCrl and BALB/cAnNCrl inbred mouse strains exhibit a similar susceptibility after infection with clonal pair of
early/late P. aeruginosa isolates. C57Bl/6NCrl (A, B) and BALB/cAnNCrl (C, D) mice were infected with 5610
6 cfu/lung of P. aeruginosa strains
from AA (A, C) and 1610
7 cfu/lung KK (B, D) clonal lineages. Survival of infected mice was followed over a period of 4 days. Early strains (AA2, KK1
and KK2) were lethal while late strains (AA43, AA44, KK71, KK72) were attenuated in acute virulence. Two to three independent experiments were
pooled (nr of mice: 5–18 as detailed in table S3). Statistical analysis was calculated for pair wise comparisons between early and late strains (*
p,0.05; ** p,0.01; *** p,0.001, Mantel-Cox test).
doi:10.1371/journal.pone.0035648.g004
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Previous studies that were based on whole genome sequence
analyses of longitudinal P. aeruginosa isolate from CF patients
suggested that bacterial invasive functions are selected against
during the course of chronic infection [5,11]. Examples include
motility, type III secretion system, O antigen biosynthesis,
exotoxin, protease, and phenazine production, among others.
Historically, many of these functions are considered to be
virulence factors, as they provoke acute infection or dissemination
within the host. Consequently, a major question that derived from
previous reports and which requires further investigation was
whether adaptation of P. aeruginosa strains to the CF-niche changes
the fitness in other environments.
In this paper, we tested this hypothesis by evaluating acute
pathogenicity of P. aeruginosa clonal variants from CF patients, in
multiple infection hosts. The P. aeruginosa clonal strains included in
this panel were isolated at different time points during CF chronic
lung infection and were genetically characterized for genome
Figure 5. Histopathology, P. aeruginosa load and localization in murine lungs after infection with clonal pair of early/late P.
aeruginosa isolates. C57Bl/6NCrl were infected with 5610
6 cfu/lung of P. aeruginosa strains from AA lineage for 24 hours. Control mice were not
infected. Lungs were stained with H&E and in immunofluorescence with specific antibody against P. aeruginosa (red) (A, E, I: AA2; B, F, L: AA43; C, G,
M: AA44; D, H, N: not infected). Counterstaining was performed with 49,6-Diamidino-2-phenylindole dihydrochloride (DAPI) (blue). I–N) Bacterial
cells of P. aeruginosa are visible in the bronchia and pulmonary parenchyma. O) Severity of lesions and lung involvement is heterogeneous in
different lobes of the same mice. Quantification of infiltrated and preserved areas as percentage of total tissue area with mean 6 SEM is shown (n=3
mice each/strain). Statistical analysis was calculated for pair wise comparisons between early and late strains (* p,0.05; ** p,0.01; *** p,0.001,
Mann–Whitney). P) Dots represent individual measurements of the no. of cfu per lung, and horizontal lines represent median values after 12, 24 and
48 h. Two independent experiments were pooled. Statistical analysis was calculated for pair wise comparisons between early and late strains (*
p,0.05, Student’s t-test).
doi:10.1371/journal.pone.0035648.g005
Figure 6. Invasion of clonal pair of early/late P. aeruginosa isolates in IB3-1 and C38 cells. A) Fold of invasion relative to AA2 after 1 h of
stimulation with AA clonal lineage. B) Fold of invasion relative to KK1 after 1 h of stimulation with KK clonal lineage. Measurements were performed
in triplicate. Statistical analysis was calculated for pair wise comparisons between early and late strains (* p,0.05, ** p,0.01, *** p,0.001, Student’s t-
test).
doi:10.1371/journal.pone.0035648.g006
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and phenotypically for the loss of motility, acquisition of mucoidy,
and a number of changes in the production of distinct virulence
factors [14,15]. Furthermore, the P. aeruginosa late strains, which
were selected for this study, clustered with respect to their ability to
persist in CF airways as well as in murine models of chronic
infection that mimic the anaerobic conditions found the CF
sputum [19,14]. When P. aeruginosa longitudinal strains were tested
in non-mammalian infection models, including C. elegans, G.
mellonella and D. melanogaster, a reduction in acute virulence was
observed in late strains relative to the respective early isolates.
Most notably, there was a general agreement between the three
models. When the panel of hosts was expanded to C57bl/6NCrl
and Balb/cAnNCrl inbred mouse strains of different genetic
backgrounds, we confirmed that early strains were lethal while late
adapted P. aeruginosa strains were attenuated in acute virulence.
Based on previous reports on P. aeruginosa and other CF-related
pathogens, this result was not obvious. In fact, the ability of
bacteria to survive in a particular environment depends on
virulence factors that are often specific for a particular host.
Recent studies of Burkholderia cenocepacia infection in C. elegans, G.
mellonella, alfalfa plant, mice and rats reported that most virulence
factors are specific for one infection model only, and virulence
factors are only rarely essential for full pathogenicity in multiple
hosts. Only three factors were found to be essential for full
pathogenicity in several host. Burkholderia cenocepacia mutants
defective in quorum sensing, siderophore production and LPS
biosynthesis were found to be attenuated in at least three of the
infection models [20]. In P. aeruginosa PA14 strain only few host-
specific virulence factors could be identified, and many of the
mutants were attenuated in virulence in different hosts including
C. elegans, G. melonella and mice [21]. However, when the virulence
factors discovered in reference strains PA14 and PAO1 were tested
in other clinical strains, no correlation between the absence and
presence of these genes with virulence was observed [21].
Comparison of various clinical P. aeruginosa strains revealed that
virulence is both multifactorial and combinatorial, the result of a
pool of pathogenicity-related genes that interact in various
combinations in different genetic background. P. aeruginosa clinical
strains from the same type of infection exhibited a wide range of
virulence in C. elegans [2]. For example, both the most and the least
virulent strains tested were isolates from CF infections. Examina-
tion of specific genes among the several P. aeruginosa isolates did not
reveal a consistent clustering of their genomic content with their
pathogenic potential.
However, distinction between early and late P. aeruginosa strains
from patients with CF had not been taken into account in previous
works. Here, we directly compared P. aeruginosa early and late
strains adapted to the CF-niche, which included strain exhibiting
diverse phenotypes and belong to different genotypes, in several
hosts. Although the genomes of P. aeruginosa isolates used in this
work were not fully sequenced and only few phenotypic differences
were identified, it is likely that late strains have accumulated
several mutations during chronic persistence which account for the
reduced pathogenicity across a broad range of hosts [14,15]. Thus,
the genetic adaptation process that leads to CF-niche specializa-
tion restricts the overall virulence of late strains to other
environmental niche. Regarding the P. aeruginosa strains selected
in this study, this process is not strain-dependent but is consistent
for all the late isolates.
We were unable to correlate the observed differences in
virulence of early and late P. aeruginosa strains with a specific
phenotype, but it is most likely that multiple mutations are
responsible for the attenuation of late strain in acute virulence.
Notably, a single phenotypic difference of the early KK1 and KK2
strains, including a LasR phenotype and a motility defect, did not
change virulence in several hosts; major pathogenic differences are
evident in KK71 and KK72, in which multiple phenotypic
changes were observed. The mucoid AA43 and the non-mucoid
AA44 strains did not differ in their virulence potential. In addition,
AA43 and AA44 were similarly attenuated despite their differences
in LPS lipid A, as has been reported previously [5].
Although rodents are the first choice for understanding
infectious diseases in human, non-mammalian models can be
useful surrogate hosts. Drosophila response to pathogens and
mammalian innate immune defenses are characterized by
pathways conserved in vertebrates [22]. C. elegans has been largely
used to identify virulence factors [23], allowing the study of
responses to infection as well as comparison of the virulence of
clinical and environmental isolates [24]. More recently both model
organisms, C. elegans and Drosophila, have been also used to study
host tolerance in addition to resistance mechanisms [25]. Their
innate immune system employs evolutionary conserved signalling
pathways [26,21]. In reference to G. mellonella, it has been shown to
correlate with mice models, when used to test P. aeruginosa
virulence [27]. The use of non-mammalian infection models has
several downsides, such as the specific temperature for the
cultivation of the nematode may inhibit expression of certain
virulence factors, the absence of the target organ and the lack of
specific receptors or pathways. However, our results demonstrate
the usefulness of these models for evaluating differences in acute
virulence of P. aeruginosa.
Regarding the mammalian host, several studies have demon-
strated that the host resistant/susceptibility response relies not only
on the animal species but also on its genetic background
[28,29,30,16]. In particular, different susceptibility to P. aeruginosa
chronic bronchopulmonary infection has been reported among
genetically well-defined inbred mouse strains when mice were
exposed to clinical strains embedded in the agar beads. Based on
the bacterial load detected in the lung after three days and two
weeks, Balb/cAnCrl mice were found to be resistant and C57Bl/
6NCrl mice were identified as susceptible in two different studies
[31,28]. So far, direct comparison of the susceptibility of murine
inbred strains to P. aeruginosa early and late strains from CF
patients has not been performed. In our study, C57Bl/6NCrl and
Balb/cAnCrl showed similar susceptibility to P. aeruginosa acute
infection in terms of mortality but differences in pathogenicity
among clonal early and late P. aeruginosa isolates observed in non-
mammalian hosts. The genetic diversity of the mice in addition to
the differences among type of infection (e.g. acute, reported in this
work, and chronic, reported in previous works) and challenge, and
bacterial origin may account for the different results
[28,29,30,16,32]. Separate breeding colonies of C57Bl/6 mice
maintained at the Charles River (‘‘NCrl’’), used in this study, or
Jackson (J), used in previous studies, have led to the emergence of
distinct substrains of C57Bl/6 mice that may explain the different
susceptibility.
However, the findings that P. aeruginosa early strains were more
lethal when compared to late strains in two different mouse genetic
backgrounds strongly support the results in non-mammalian hosts
that CF-niche adaptation of P. aeruginosa selects populations with
reduced pathogenic potential in the acute infections. In addition, it
has been argued that a high burden of infection but low virulence
should account for host tolerance [33,34,25]. Consequently, our
results indicated an increased host tolerance against P. aeruginosa
CF adapted strains, as suggested by the high bacterial load
sustained by the host. Our previous study showed that PAMPs of
these P. aeruginosa strains, which were isolated at the late stage of
Virulence of P. aeruginosa Patho-Adaptive Variants
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system suggesting a role of adaptation in increasing host tolerance
[5,35,25]. Histopathological analysis carried out in this work
supports the previous findings that detection of P. aeruginosa
adaptive strains is impaired compared to early strains. The
mechanism(s) that permits P. aeruginosa to cause invasive infections
with bacteremia or tolerance is not known. Some bacterial
pathogens can induce their own uptake into host cells (invasion),
allowing the pathogen to enter a protected niche and, in some
cases, to pass through cellular barriers including the respiratory
epithelium and/or the blood barrier [17,18]. Although further
studies are needed to determine the exact mechanisms of P.
aeruginosa/host interaction, it is tempting to speculate that the
invasiveness of P. aeruginosa early strains may facilitate spreading
from the lung to other tissues, while P. aeruginosa late strains, which
are not able to protect themselves, may be finally eliminated.
Taken together, our results demonstrate that P. aeruginosa
adaptation in CF airways selects pathoadaptive variants with a
strongly reduced ability to cause acute infection processes in a
host-independent way. These results have important implications
for our understanding of the pathogenesis of P. aeruginosa-host
interaction.
Materials and Methods
Ethics Statement
Animal studies were conducted according to protocols approved
by the San Raffaele Scientific Institute (Milan, Italy) Institutional
Animal Care and Use Committee (IACUC) and adhered strictly to
the Italian Ministry of Health guidelines for the use and care of
experimental animals.
Research on the bacterial isolates from the individuals with CF
has been approved by the responsible physician at the CF center at
Hannover Medical School, Germany. All patients gave informed
consent before the sample collection. Approval for storing of
biological materials was obtained by the Hannover Medical
School, Germany.
Bacterial strains and CF patient
Nine sequential P. aeruginosa isolates from three CF patient
carrying DF508/DF508 or DF508/R553X cftr mutation were
chosen from the strains collection of the CF clinic Medizinische
Hochschule of Hannover, Germany. Genotypic and phenotypic
data of P. aeruginosa strains were published previously and
summarized in Figure 1 and Table S1 [4,14,5]. P. aeruginosa
was cultured in Pseudomonas isolation agar (PIA) or Trypticase Soy
Broth (TSB) at 37uC.
Investigation of pathogenicity in the C. elegans model
For the investigation of pathogenicity C. elegans strain DH26 has
been used. Worms were synchronized into L4 larval stage by egg
preparation, which was followed by incubation of isolated eggs on
E. coli OP50 feeding plates at 20uC for around 76 hours.
Subsequently, L4 larvae were transferred on the lawns of
examined bacterial strains grown in the 6-well plates (approxi-
mately 30 worms per well) and incubated at 25uC. The surviving
worms were counted after 24, 48 and 72 hours with the aid of a
Stemi SV 6 microscope (Zeiss, Goettingen). The pathogenicity of
the investigated bacterial strains was determined from the survival
rates of C. elegans in three independent replicates.
G. mellonella killing assays
Infection of G. mellonella larvae was performed as described
previously [27], with some modifications. Caterpillars in the final
larval stage (Brumann, Zurich, Switzerland) were stored in
wooden shavings at 15uC and used within 2 to 3 weeks. Bacterial
overnight cultures grown in LB broth were diluted 1:100 in 30 ml
fresh medium and grown to an OD600 of 0.4 to 0.7. Cultures were
centrifuged and the cellswere resuspended in 10 mM MgSO4 (E.
Merck, Dietikon, Switzerland). 10-ml aliquots of three dilutions
were injected into G. mellonella via the hindmost proleg using a 1-ml
syringe (BD Plastipak, Madrid, Spain) with a 27-gauge needle
(Rose GmbH, Trier, Germany).. Six healthy, randomly chosen
larvae were injected and incubated at 30uC in the dark. As a
control larvae were injected with 10 ml MgSO4. The number of
dead larvae was scored 24 h after infection and the LD50 dosage
was determined. Data are mean values for at least three
independent experiments.
Fly pathogenicity assay
Fly pricking assays were performed essentially as described by
Apidianianakis et al [36]. 1 ml of an overnight culture was pelleted
by centrifugation (10 min by 5000 rpm) and re-suspended in 1 ml
of 10 mM MgSO4 solution. A Tungsten stainless steel needle, with
approximate diameters of 0.01 mm at the tip and 0.2 mm across
the main needle body, was dipped into the bacterial solution and
pricked into the middle dorsolateral thorax of anesthetized flies.
For each strain 15 flies were used. As a control, the flies were
pricked with MgSO4 buffer. The infected flies were kept in glass
vials, which were incubated at 26uC. Survival of the flies was
monitored over time.
Mouse model of acute P. aeruginosa infection
C57Bl/6 mice (20–22 gr) were purchased by Charles River.
Mice were housed in filtered cages under specific-pathogen
conditions and permitted unlimited access to food and water.
Prior to animal experiments, the clinical P. aeruginosa strains were
grown for 3 h to reach exponential phase. Next, the bacteria were
pelleted by centrifugation (2700 g, 15 min), washed twice with
sterile PBS and the OD of the bacterial suspension was adjusted by
spectrophotometry at 600 nm. The intended number of cfu was
extrapolated from a standard growth curve. Appropriate dilutions
with sterile PBS were made to prepare the inoculum of 2610
6 up
to 2610
10 cfu/ml. Mice were anesthetized and the trachea
directly visualized by a ventral midline incision, exposed and
intubated with a sterile, flexible 22-g cannula attached to a 1 ml
syringe according to established procedures [14] [37]. A 50 ml
inoculum of 1610
5 up to 1610
9 cfu were implanted via the
cannula into the lung, with both lobes inoculated. After infection,
mortality and body weight were monitored in one group of mice
over one week. In another group of mice, the lungs were excised,
used for histopathology, homogenized and plated onto TSB-agar
plates for cfu counting.
Histological examination and immunofluorescence
Mice were sacrificed by CO2 administration after 12, 24, 48 h
of infection, lungs were removed en bloc and fixed in 10%
buffered formalin at 4uC for 24 h, and processed for paraffin
embedding. Longitudinal sections of 5 mm from the proximal,
medial and distal lung regions were obtained at regular intervals
using a microtome. Sections were stained with H&E according to
standard procedures. Areas of inflammatory cell infiltration and
tissue preservation (normal histology) were quantified using Image
J software (National Institutes of Health) and reported as a
percentage of total area [38]. Localization of P. aeruginosa was
performed in de-paraffinized lung sections by employing a rabbit
antiserum specific for P. aeruginosa and Texas Red-labeled goat
anti-rabbit IgG as described [14]. The slides were examined using
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taken with a KS 300 imaging system (Kontron).
Cell cultures and invasion assay
IB3-1 cells, an adeno-associated virus-transformed human
bronchial epithelial cell line derived from a CF patient (DF508/
W1282X) and C38 cells, the rescued cell line which expresses a
plasmid encoding a copy of functional CFTR, were obtained from
LGC Promochem [39]. Cells were grown in LHC-8 media
(Biosource) supplemented with 5% fetal bovine serum (FBS)
(Cambrex Bio Science). All culture flasks and plates were coated
with a solution of LHC-basal medium (Biosource) containing
35 mg/mL bovine collagen (BD Biosciences), 1 mg/mL bovine
serum albumin (BSA, Sigma) and 10 mg/mL human fibronectin
(BD Bio Science) as described [40].
Bacteria invasion assay was performed using Polymyxins B
(100 mg/ml) (Sigma) protection assay with minor modifications
[41]. P. aeruginosa strains, grown to the mid-exponential phase,
were used to infect cell monolayers at a 100:1 multiplicity of
infection for 1 h. The monolayers were washed with PBS, treated
with antibiotic for 1 h, washed, lysed with H2O and plated on
TSB-agar plates (Difco).
Statistical analysis
Results are presented as median or mean6SEM. Student’s t-
test, Mann-Whitney test, Mantel-Cox test were used to determine
the significance of differences in means between pairs.
Supporting Information
Figure S1 Weight change after infection with clonal pair
of early/late P. aeruginosa isolates in C57Bl/6NCrl and
BALB/cAnNCrl inbred mouse strains. (A) C57Bl/6NCrl
weights after infection with P. aeruginosa AA clonal lineage; (B)
C57Bl/6NCrl weights after infection with P. aeruginosa KK clonal
lineage; (C) BALB/cAnNCrl weights after infection with P.
aeruginosa AA clonal lineage; (D) BALB/cAnNCrl weights after
infection with P. aeruginosa KK clonal lineage. Data are expressed
as mean 6 SEM. Two to three independent experiments were
pooled (nr of mice: 5–18 as detailed in table S3).
(TIF)
Table S1 Genotypic and phenotypic characteristics of
P. aeruginosa strains used in this work.
(DOC)
Table S2 Dose response in C57Bl/6NCrl infected with
P. aeruginosa clonal lineages.
(DOC)
Table S3 Comparison between C57Bl/6NCrl and
BALB/cAnCrl infected with P. aeruginosa clonal lineag-
es.
(DOC)
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